| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 3.72e-05 | 6 | 32 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity | 3.72e-05 | 6 | 32 | 2 | GO:0017083 | |
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 6.92e-05 | 8 | 32 | 2 | GO:0046920 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 8.89e-05 | 9 | 32 | 2 | GO:0015185 | |
| GeneOntologyMolecularFunction | fucosyltransferase activity | 2.24e-04 | 14 | 32 | 2 | GO:0008417 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 2.58e-04 | 15 | 32 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 3.33e-04 | 17 | 32 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 4.18e-04 | 19 | 32 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 4.18e-04 | 19 | 32 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.16e-04 | 23 | 32 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.16e-04 | 23 | 32 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 7.89e-04 | 26 | 32 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 9.83e-04 | 29 | 32 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.04e-03 | 125 | 32 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.43e-03 | 35 | 32 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.44e-03 | 793 | 32 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.79e-03 | 151 | 32 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.55e-03 | 171 | 32 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.55e-03 | 171 | 32 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.83e-03 | 664 | 32 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.29e-03 | 61 | 32 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.36e-03 | 207 | 32 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.42e-03 | 208 | 32 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.95e-03 | 459 | 32 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 6.69e-03 | 758 | 32 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.45e-03 | 81 | 32 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 7.81e-03 | 83 | 32 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 9.13e-03 | 90 | 32 | 2 | GO:0008028 | |
| GeneOntologyMolecularFunction | channel activity | 9.48e-03 | 525 | 32 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 9.54e-03 | 526 | 32 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.01e-02 | 1180 | 32 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.13e-02 | 293 | 32 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.16e-02 | 296 | 32 | 3 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.22e-02 | 301 | 32 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.23e-02 | 105 | 32 | 2 | GO:0015171 | |
| GeneOntologyBiologicalProcess | fucose catabolic process | 8.34e-05 | 9 | 32 | 2 | GO:0019317 | |
| GeneOntologyBiologicalProcess | L-fucose catabolic process | 8.34e-05 | 9 | 32 | 2 | GO:0042355 | |
| GeneOntologyBiologicalProcess | L-fucose metabolic process | 1.04e-04 | 10 | 32 | 2 | GO:0042354 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.26e-04 | 63 | 32 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | fucose metabolic process | 2.76e-04 | 16 | 32 | 2 | GO:0006004 | |
| Domain | LRRCT | 2.19e-05 | 32 | 32 | 3 | PF01463 | |
| Domain | EPTP | 4.25e-05 | 6 | 32 | 2 | IPR005492 | |
| Domain | EPTP | 4.25e-05 | 6 | 32 | 2 | PF03736 | |
| Domain | EAR | 5.94e-05 | 7 | 32 | 2 | IPR009039 | |
| Domain | EAR | 5.94e-05 | 7 | 32 | 2 | PS50912 | |
| Domain | Glyco_transf_10 | 7.91e-05 | 8 | 32 | 2 | PF00852 | |
| Domain | Glyco_tran_10_N | 7.91e-05 | 8 | 32 | 2 | PF17039 | |
| Domain | Glyco_trans_10 | 7.91e-05 | 8 | 32 | 2 | IPR001503 | |
| Domain | Glyco_tran_10_N | 7.91e-05 | 8 | 32 | 2 | IPR031481 | |
| Domain | Gal_mutarotase_SF_dom | 3.81e-04 | 17 | 32 | 2 | IPR011013 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.28e-04 | 18 | 32 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.78e-04 | 19 | 32 | 2 | PS50267 | |
| Domain | SNF | 4.78e-04 | 19 | 32 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 4.78e-04 | 19 | 32 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.78e-04 | 19 | 32 | 2 | PS00610 | |
| Domain | Cys-rich_flank_reg_C | 4.85e-04 | 90 | 32 | 3 | IPR000483 | |
| Domain | LRRCT | 4.85e-04 | 90 | 32 | 3 | SM00082 | |
| Domain | LRR_1 | 5.11e-04 | 219 | 32 | 4 | PF00560 | |
| Domain | Leu-rich_rpt | 1.13e-03 | 271 | 32 | 4 | IPR001611 | |
| Domain | - | 2.11e-03 | 321 | 32 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 2.28e-03 | 328 | 32 | 4 | IPR032675 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.81e-03 | 46 | 32 | 2 | IPR011042 | |
| Domain | LRR_8 | 3.08e-03 | 171 | 32 | 3 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.39e-03 | 177 | 32 | 3 | IPR003591 | |
| Domain | LRR_TYP | 3.39e-03 | 177 | 32 | 3 | SM00369 | |
| Domain | FBOX | 3.57e-03 | 52 | 32 | 2 | SM00256 | |
| Domain | p53-like_TF_DNA-bd | 3.71e-03 | 53 | 32 | 2 | IPR008967 | |
| Domain | SCAN | 4.13e-03 | 56 | 32 | 2 | SM00431 | |
| Domain | SCAN_BOX | 4.43e-03 | 58 | 32 | 2 | PS50804 | |
| Domain | SCAN | 4.43e-03 | 58 | 32 | 2 | PF02023 | |
| Domain | SCAN_dom | 4.43e-03 | 58 | 32 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 4.58e-03 | 59 | 32 | 2 | IPR008916 | |
| Domain | F-box | 5.87e-03 | 67 | 32 | 2 | PF00646 | |
| Domain | FBOX | 6.75e-03 | 72 | 32 | 2 | PS50181 | |
| Domain | F-box_dom | 7.30e-03 | 75 | 32 | 2 | IPR001810 | |
| Domain | Znf_PHD-finger | 8.07e-03 | 79 | 32 | 2 | IPR019787 | |
| Domain | PHD | 1.01e-02 | 89 | 32 | 2 | SM00249 | |
| Domain | Znf_PHD | 1.06e-02 | 91 | 32 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.15e-02 | 95 | 32 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.17e-02 | 96 | 32 | 2 | PS01359 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 2.11e-05 | 5 | 21 | 2 | M47966 | |
| Pathway | WP_CREATINE_PATHWAY | 2.11e-05 | 5 | 21 | 2 | M45546 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 3.16e-05 | 6 | 21 | 2 | M47967 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.90e-04 | 14 | 21 | 2 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.90e-04 | 14 | 21 | 2 | M27564 | |
| Pathway | BIOCARTA_AMAN_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M22009 | |
| Pathway | REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS | 4.36e-04 | 21 | 21 | 2 | M27917 | |
| Pathway | KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES | 6.72e-04 | 26 | 21 | 2 | M17377 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17604274 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 1339443 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 24842606 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 7650030 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 30808544 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 7782074 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 19833108 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 28771224 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 19349624 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 38194969 | ||
| Pubmed | Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells. | 8.19e-06 | 5 | 32 | 2 | 29593094 | |
| Pubmed | The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. | 1.23e-05 | 6 | 32 | 2 | 12217514 | |
| Pubmed | A common protein interaction domain links two recently identified epilepsy genes. | 1.23e-05 | 6 | 32 | 2 | 12095917 | |
| Pubmed | The claw paw mutation reveals a role for Lgi4 in peripheral nerve development. | 1.72e-05 | 7 | 32 | 2 | 16341215 | |
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 33374598 | ||
| Pubmed | Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. | 8.55e-05 | 15 | 32 | 2 | 11698403 | |
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 1.70e-04 | 21 | 32 | 2 | 16125675 | |
| Pubmed | 1.70e-04 | 21 | 32 | 2 | 25707359 | ||
| Pubmed | 3.05e-04 | 28 | 32 | 2 | 24427155 | ||
| GeneFamily | Fucosyltransferases|Blood group antigens | 1.20e-04 | 13 | 23 | 2 | 434 | |
| GeneFamily | PHD finger proteins | 5.79e-03 | 90 | 23 | 2 | 88 | |
| GeneFamily | Solute carriers | 1.33e-02 | 395 | 23 | 3 | 752 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 4.64e-06 | 156 | 32 | 4 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 4.64e-06 | 156 | 32 | 4 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-06 | 165 | 32 | 4 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-06 | 165 | 32 | 4 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-06 | 165 | 32 | 4 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.93e-06 | 166 | 32 | 4 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 6.36e-06 | 169 | 32 | 4 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 6.51e-06 | 170 | 32 | 4 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 186 | 32 | 4 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.69e-06 | 188 | 32 | 4 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.69e-06 | 188 | 32 | 4 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 192 | 32 | 4 | 7ccdb977320d09f21e70e7718ead73eeb56d0c48 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 192 | 32 | 4 | 69963e8dc6d6368243e61da133484eb23225625a | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 192 | 32 | 4 | bfc68af68fdb99ddfe4add49671e4b4c26e6f962 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 192 | 32 | 4 | f206c015f091234e2c86dfa66926e97b2ea99690 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-05 | 194 | 32 | 4 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 138 | 32 | 3 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 1.52e-04 | 145 | 32 | 3 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 1.52e-04 | 145 | 32 | 3 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 150 | 32 | 3 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-04 | 156 | 32 | 3 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.22e-04 | 165 | 32 | 3 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 166 | 32 | 3 | a42268a02a89fc97272e45c4cbe21acf04b7428c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-04 | 167 | 32 | 3 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-04 | 167 | 32 | 3 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.34e-04 | 168 | 32 | 3 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 170 | 32 | 3 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.43e-04 | 170 | 32 | 3 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.47e-04 | 171 | 32 | 3 | 0bf36930bd7fc63691f48a15db93deb1dd937c10 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.47e-04 | 171 | 32 | 3 | 0f8d038858a4618b4348becc26a618d43b10d9d6 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.47e-04 | 171 | 32 | 3 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.47e-04 | 171 | 32 | 3 | 791d37fe94ff2820fb409bbd38b31799df700ba1 | |
| ToppCell | Epithelial-Epithelial-C_(AT2)|Epithelial / shred on cell class and cell subclass (v4) | 2.55e-04 | 173 | 32 | 3 | f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 2.60e-04 | 174 | 32 | 3 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.60e-04 | 174 | 32 | 3 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.64e-04 | 175 | 32 | 3 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.69e-04 | 176 | 32 | 3 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 2.69e-04 | 176 | 32 | 3 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 176 | 32 | 3 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-04 | 176 | 32 | 3 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 178 | 32 | 3 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 178 | 32 | 3 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 178 | 32 | 3 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 178 | 32 | 3 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 179 | 32 | 3 | 40441de2d679733ecbf2145fabc3ed65a53310eb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.91e-04 | 181 | 32 | 3 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 182 | 32 | 3 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.96e-04 | 182 | 32 | 3 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.01e-04 | 183 | 32 | 3 | 23e55f88a802a9299d2773f9394970e86e8bbfaa | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-04 | 183 | 32 | 3 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.01e-04 | 183 | 32 | 3 | 0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26 | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 24cbe9f2461ea920954e44bf3b2c2a6a5d4debfb | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 86c1551c4f7c7d0c35c14852b01b1e602fa5092a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-04 | 184 | 32 | 3 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 3.06e-04 | 184 | 32 | 3 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 98079fd048a63b51bbdf3833b6f15bf0ae99ea90 | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 3.06e-04 | 184 | 32 | 3 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 3.06e-04 | 184 | 32 | 3 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 3.16e-04 | 186 | 32 | 3 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-04 | 186 | 32 | 3 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-04 | 186 | 32 | 3 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 3.16e-04 | 186 | 32 | 3 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 187 | 32 | 3 | e176b5b051690f840f3b12c8f7c4cc10cbe2bbae | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 187 | 32 | 3 | 6ab51e17a7782c2ae6394cad813dc3a2cde70c89 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 3.21e-04 | 187 | 32 | 3 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 3.21e-04 | 187 | 32 | 3 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.26e-04 | 188 | 32 | 3 | 229d24b87e945c4d543d11ac70761e45175ba0e5 | |
| ToppCell | normal_Lung-MAST_cells-MAST|normal_Lung / Location, Cell class and cell subclass | 3.31e-04 | 189 | 32 | 3 | fd053209034fca6eaefe0e5ad024ac4548a100c9 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 189 | 32 | 3 | 1893765b1e3b306f1e133101c28403070a70c3c8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 189 | 32 | 3 | 19b639bc6b35fe1d1079f60c8138aa946a95f3bf | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 189 | 32 | 3 | b59cc66f7bb9b72895b775fbcf1ec1dc08610969 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 189 | 32 | 3 | f3cb1a8ddf7a4a95fb1b6e8fe5aa63ef037ca7a6 | |
| ToppCell | normal_Lung-MAST_cells|normal_Lung / Location, Cell class and cell subclass | 3.31e-04 | 189 | 32 | 3 | f09e387dc0626536050cd537dda212471a7267c4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 189 | 32 | 3 | 96566f84c796d5b2e31f64090555f2b258f0c9f2 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-04 | 190 | 32 | 3 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-04 | 190 | 32 | 3 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-04 | 190 | 32 | 3 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 3.36e-04 | 190 | 32 | 3 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 190 | 32 | 3 | aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.36e-04 | 190 | 32 | 3 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 190 | 32 | 3 | a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 191 | 32 | 3 | 2f71f1fb6b5872d84860840b22e789a87ab14eec | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-04 | 191 | 32 | 3 | f98fc372e579ce69409afbbe0f83c03c7ea62632 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-04 | 191 | 32 | 3 | 210589095a3f5d5117174caf6ec110b502f27030 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 191 | 32 | 3 | 4ab3056f9af2a6caed39f32288562f480811cd7b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 191 | 32 | 3 | 5f8b3b2d38b37027901db9a1cccdbd1ff70f29de | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-04 | 192 | 32 | 3 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-04 | 192 | 32 | 3 | 6244541688f85917018a057aa0b3e5972934dfbc | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-04 | 192 | 32 | 3 | 4a46f7980ec145be5b4bf8b98265e3e0f2ea4c63 | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| Disease | alpha-(1;3)-fucosyltransferase 5 measurement | 5.59e-06 | 4 | 29 | 2 | EFO_0021979 | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 1.95e-05 | 7 | 29 | 2 | EFO_0021853 | |
| Disease | alpha-(1,3)-fucosyltransferase 5 measurement | 1.95e-05 | 7 | 29 | 2 | EFO_0020136 | |
| Disease | serum carcinoembryonic antigen measurement | 1.75e-04 | 20 | 29 | 2 | EFO_0005760 | |
| Disease | unipolar depression, depressive symptom measurement | 2.99e-04 | 26 | 29 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | internet addiction disorder | 4.83e-04 | 33 | 29 | 2 | EFO_0803368 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 4.83e-04 | 33 | 29 | 2 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | epilepsy (implicated_via_orthology) | 5.44e-04 | 163 | 29 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | candidiasis (implicated_via_orthology) | 8.60e-04 | 44 | 29 | 2 | DOID:1508 (implicated_via_orthology) | |
| Disease | peak expiratory flow | 1.36e-03 | 498 | 29 | 4 | EFO_0009718 | |
| Disease | Autistic Disorder | 2.11e-03 | 261 | 29 | 3 | C0004352 | |
| Disease | obsolete aging | 2.55e-03 | 279 | 29 | 3 | GO_0007568 | |
| Disease | S-warfarin measurement | 4.10e-03 | 97 | 29 | 2 | EFO_0803323 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGCWILKFEWVKACL | 626 | Q99728 | |
| KWICATEIEDDKFLW | 876 | Q008S8 | |
| VEAFKEWKEWIIKCL | 341 | Q86W34 | |
| LKLKWCAWVAVYCSF | 51 | Q9Y284 | |
| KAAWDVEWAVLKCRL | 1171 | Q9Y4B5 | |
| IGVQTWVLWKHCKDC | 206 | Q7RTS5 | |
| CWENWLAICRKLKLD | 936 | O00370 | |
| TDKCIPFWWKCDTVD | 3326 | Q9NZR2 | |
| GSWSCHLCWELLKEK | 356 | Q92784 | |
| ANEKEPCCWWLAKVR | 71 | Q06787 | |
| VCKTWYKWCCDKRLW | 916 | Q9Y2K7 | |
| YKWCCDKRLWTKIDL | 921 | Q9Y2K7 | |
| CDPVCKIVDWALSVW | 1301 | Q8WZ74 | |
| WKAVALIWLVACCFP | 166 | Q8TDV2 | |
| CSCDIPAIWKSIFLW | 311 | P47898 | |
| SWALAFCKACWKLQE | 331 | P51993 | |
| IKIGWVCDLDKAWDQ | 241 | P56373 | |
| KNWLEEECIAWLKRF | 176 | Q95460 | |
| WALAFCKACWKLQQE | 346 | Q11128 | |
| CFSAKALCVWIWALA | 211 | Q9NSD7 | |
| LVWLVCFFCIWKGVR | 226 | P31641 | |
| WRKSKLDCCIWVVSF | 456 | Q7LBE3 | |
| LWTQQDVCKWLKKHC | 76 | Q8N8I0 | |
| ACWVLVYFCVWKGVK | 241 | P48029 | |
| VFLIWDCCDAWLKVK | 736 | Q9NY46 | |
| WKDVVCTCSLKNWRE | 631 | Q9NQW1 | |
| VIKETKDWDAWKVCL | 381 | P04181 | |
| LKCEWELLERKAVAW | 741 | O00534 | |
| EDGLICIWDAKKWEC | 101 | Q9NWT1 | |
| CIWDAKKWECLKSIK | 106 | Q9NWT1 | |
| EAFSKLWELCCRWLK | 61 | Q63HK3 | |
| EAFNKLWELCCQWLK | 46 | Q6P9G9 | |
| NCDCKLKWLVEWLGH | 176 | O95970 | |
| SLNCDCKVKWLVEWL | 171 | Q8N145 | |
| LCDCHLKWLLQWLVD | 446 | O94898 |